» Articles » PMID: 38577527

Protein Succinylation, Hepatic Metabolism, and Liver Diseases

Overview
Journal World J Hepatol
Specialty Gastroenterology
Date 2024 Apr 5
PMID 38577527
Authors
Affiliations
Soon will be listed here.
Abstract

Succinylation is a highly conserved post-translational modification that is processed enzymatic and non-enzymatic mechanisms. Succinylation exhibits strong effects on protein stability, enzyme activity, and transcriptional regulation. Protein succinylation is extensively present in the liver, and increasing evidence has demonstrated that succinylation is closely related to hepatic metabolism. For instance, histone acetyltransferase 1 promotes liver glycolysis, and the sirtuin 5-induced desuccinylation is involved in the regulation of the hepatic urea cycle and lipid metabolism. Therefore, the effects of succinylation on hepatic glucose, amino acid, and lipid metabolism under the action of various enzymes will be discussed in this work. In addition, how succinylases regulate the progression of different liver diseases will be reviewed, including the desuccinylation activity of sirtuin 7, which is closely associated with fatty liver disease and hepatitis, and the actions of lysine acetyltransferase 2A and histone acetyltransferase 1 that act as succinyltransferases to regulate the succinylation of target genes that influence the development of hepatocellular carcinoma. In view of the diversity and significance of protein succinylation, targeting the succinylation pathway may serve as an attractive direction for the treatment of liver diseases.

Citing Articles

Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation.

Wang Z, Liu Z, Lv M, Luan Z, Li T, Hu J Clin Epigenetics. 2025; 17(1):30.

PMID: 39980025 PMC: 11841274. DOI: 10.1186/s13148-025-01838-8.


Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development.

Ke Z, Shen K, Wang L, Xu H, Pan X, Qian Z Front Immunol. 2025; 16:1531246.

PMID: 39944690 PMC: 11814216. DOI: 10.3389/fimmu.2025.1531246.

References
1.
OConnell T, Golzarri-Arroyo L, Pin F, Barreto R, Dickinson S, Couch M . Metabolic Biomarkers for the Early Detection of Cancer Cachexia. Front Cell Dev Biol. 2021; 9:720096. PMC: 8490779. DOI: 10.3389/fcell.2021.720096. View

2.
de Martel C, Maucort-Boulch D, Plummer M, Franceschi S . World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015; 62(4):1190-200. PMC: 5019261. DOI: 10.1002/hep.27969. View

3.
Veneti S, Grammatikopoulou M, Kintiraki E, Mintziori G, Goulis D . Ketone Bodies in Diabetes Mellitus: Friend or Foe?. Nutrients. 2023; 15(20). PMC: 10609881. DOI: 10.3390/nu15204383. View

4.
Yuan Y, Yuan H, Geng Y, Zhao L, Yun H, Wang Y . Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells. Biochem Biophys Res Commun. 2021; 560:172-178. DOI: 10.1016/j.bbrc.2021.04.083. View

5.
Yuan H, Zhao M, Zhao L, Yun H, Yang G, Geng Y . PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours. Acta Pharmacol Sin. 2022; 43(9):2373-2385. PMC: 9433386. DOI: 10.1038/s41401-021-00841-y. View